Summary

The global Antiandrogen Drugs market size is predicted to grow from US$ 8051 million in 2025 to US$ 11288 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.
Antiandrogen Drugs are pharmacological agents that directly block or inhibit androgen receptor activity and thereby reduce the biological effects of testosterone, dihydrotestosterone and related androgens in androgen-responsive tissues. This study focuses on direct androgen receptor antagonists used primarily in prostate cancer, covering first-generation agents such as bicalutamide, flutamide and nilutamide and next-generation androgen receptor inhibitors such as enzalutamide, apalutamide and darolutamide. The market is predominantly composed of small-molecule oral solid dosage forms, including tablets, film-coated tablets, capsules and soft capsules, with product specifications differentiated by active ingredient, strength, formulation, dosing schedule and approved disease setting. The therapeutic mechanism centers on preventing androgen-driven receptor signaling and, for newer agents, more comprehensive inhibition of androgen receptor activation, nuclear translocation and downstream transcriptional activity. Antiandrogen Drugs are used across castration-sensitive and castration-resistant prostate cancer settings, often together with medical or surgical androgen-deprivation strategies depending on the specific approved indication.
United States market for Antiandrogen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Antiandrogen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Antiandrogen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Antiandrogen Drugs players cover Astellas Pharma Inc., Johnson & Johnson Innovative Medicine, Bayer AG, ANI Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LPI (LP Information)' newest research report, the “Antiandrogen Drugs Industry Forecast” looks at past sales and reviews total world Antiandrogen Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Antiandrogen Drugs sales for 2026 through 2032. With Antiandrogen Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiandrogen Drugs industry.
This Insight Report provides a comprehensive analysis of the global Antiandrogen Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antiandrogen Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiandrogen Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiandrogen Drugs and breaks down the forecast by Structure, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiandrogen Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiandrogen Drugs market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Structure:
Nonsteroidal Antiandrogens
Steroidal Antiandrogens
Segmentation by Shape:
Tablets
Capsules
Soft Capsules
Segmentation by Application:
Non-Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Sensitive Prostate Cancer
High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Astellas Pharma Inc.
Johnson & Johnson Innovative Medicine
Bayer AG
ANI Pharmaceuticals, Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Apotex Inc.
Intas Pharmaceuticals Ltd.
Cipla Ltd.
Zydus Lifesciences Ltd.
Sandoz Group AG
Pinnacle Life Science Pvt. Ltd.
Orion Corporation
Zhejiang Hisun Pharmaceutical Co., Ltd.
Shanghai Fudan Forward Pharmaceutical Co., Ltd.
Shanghai Zhaohui Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Aurisco Pharmaceutical Co., Ltd.
Qilu Pharmaceutical (Hainan) Co., Ltd.
Chengdu Easton Biopharmaceuticals Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Yangtze River Pharmaceutical Group Co., Ltd.
Zhejiang Nuode Pharmaceutical Co., Ltd.
Jiangxi Kerui Pharmaceutical Co., Ltd.
Chengdu Better Pharmaceutical Co., Ltd.
Shenyang Hongqi Pharmaceutical Co., Ltd.
Yichang Humanwell Pharmaceutical Co., Ltd.

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antiandrogen Drugs Market Size (2021-2032)
2.1.2 Antiandrogen Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Antiandrogen Drugs by Country/Region (2021, 2025 & 2032)
2.2 Antiandrogen Drugs Segment by Structure
2.2.1 Nonsteroidal Antiandrogens
2.2.2 Steroidal Antiandrogens
2.2.3 Antiandrogen Drugs Market Size by Structure
2.2.3.1 Antiandrogen Drugs Market Size CAGR by Structure (2021 VS 2025 VS 2032)
2.2.3.2 Global Antiandrogen Drugs Market Size Market Share by Structure (2021-2026)
2.3 Antiandrogen Drugs Segment by Shape
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Soft Capsules
2.3.4 Antiandrogen Drugs Market Size by Shape
2.3.4.1 Antiandrogen Drugs Market Size CAGR by Shape (2021 VS 2025 VS 2032)
2.3.4.2 Global Antiandrogen Drugs Market Size Market Share by Shape (2021-2026)
2.4 Antiandrogen Drugs Segment by Application
2.4.1 Non-Metastatic Castration-Resistant Prostate Cancer
2.4.2 Metastatic Castration-Resistant Prostate Cancer
2.4.3 Metastatic Castration-Sensitive Prostate Cancer
2.4.4 High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
2.4.5 Antiandrogen Drugs Market Size by Application
2.4.5.1 Antiandrogen Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.5.2 Global Antiandrogen Drugs Market Size Market Share by Application (2021-2026)

3 Antiandrogen Drugs Market Size by Player
3.1 Antiandrogen Drugs Market Size Market Share by Player
3.1.1 Global Antiandrogen Drugs Revenue by Player (2021-2026)
3.1.2 Global Antiandrogen Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Antiandrogen Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Antiandrogen Drugs by Region
4.1 Antiandrogen Drugs Market Size by Region (2021-2026)
4.2 Global Antiandrogen Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antiandrogen Drugs Market Size Growth (2021-2026)
4.4 APAC Antiandrogen Drugs Market Size Growth (2021-2026)
4.5 Europe Antiandrogen Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Antiandrogen Drugs Market Size Growth (2021-2026)

5 Americas
5.1 Americas Antiandrogen Drugs Market Size by Country (2021-2026)
5.2 Americas Antiandrogen Drugs Market Size by Structure (2021-2026)
5.3 Americas Antiandrogen Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Antiandrogen Drugs Market Size by Region (2021-2026)
6.2 APAC Antiandrogen Drugs Market Size by Structure (2021-2026)
6.3 APAC Antiandrogen Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Antiandrogen Drugs Market Size by Country (2021-2026)
7.2 Europe Antiandrogen Drugs Market Size by Structure (2021-2026)
7.3 Europe Antiandrogen Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Antiandrogen Drugs by Region (2021-2026)
8.2 Middle East & Africa Antiandrogen Drugs Market Size by Structure (2021-2026)
8.3 Middle East & Africa Antiandrogen Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Antiandrogen Drugs Market Forecast
10.1 Global Antiandrogen Drugs Forecast by Region (2027-2032)
10.1.1 Global Antiandrogen Drugs Forecast by Region (2027-2032)
10.1.2 Americas Antiandrogen Drugs Forecast
10.1.3 APAC Antiandrogen Drugs Forecast
10.1.4 Europe Antiandrogen Drugs Forecast
10.1.5 Middle East & Africa Antiandrogen Drugs Forecast
10.2 Americas Antiandrogen Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Antiandrogen Drugs Forecast
10.2.2 Canada Market Antiandrogen Drugs Forecast
10.2.3 Mexico Market Antiandrogen Drugs Forecast
10.2.4 Brazil Market Antiandrogen Drugs Forecast
10.3 APAC Antiandrogen Drugs Forecast by Region (2027-2032)
10.3.1 China Antiandrogen Drugs Market Forecast
10.3.2 Japan Market Antiandrogen Drugs Forecast
10.3.3 Korea Market Antiandrogen Drugs Forecast
10.3.4 Southeast Asia Market Antiandrogen Drugs Forecast
10.3.5 India Market Antiandrogen Drugs Forecast
10.3.6 Australia Market Antiandrogen Drugs Forecast
10.4 Europe Antiandrogen Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Antiandrogen Drugs Forecast
10.4.2 France Market Antiandrogen Drugs Forecast
10.4.3 UK Market Antiandrogen Drugs Forecast
10.4.4 Italy Market Antiandrogen Drugs Forecast
10.4.5 Russia Market Antiandrogen Drugs Forecast
10.5 Middle East & Africa Antiandrogen Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Antiandrogen Drugs Forecast
10.5.2 South Africa Market Antiandrogen Drugs Forecast
10.5.3 Israel Market Antiandrogen Drugs Forecast
10.5.4 Turkey Market Antiandrogen Drugs Forecast
10.6 Global Antiandrogen Drugs Forecast by Structure (2027-2032)
10.7 Global Antiandrogen Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Antiandrogen Drugs Forecast

11 Key Players Analysis
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Information
11.1.2 Astellas Pharma Inc. Antiandrogen Drugs Product Offered
11.1.3 Astellas Pharma Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Astellas Pharma Inc. Main Business Overview
11.1.5 Astellas Pharma Inc. Latest Developments
11.2 Johnson & Johnson Innovative Medicine
11.2.1 Johnson & Johnson Innovative Medicine Company Information
11.2.2 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product Offered
11.2.3 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Johnson & Johnson Innovative Medicine Main Business Overview
11.2.5 Johnson & Johnson Innovative Medicine Latest Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Antiandrogen Drugs Product Offered
11.3.3 Bayer AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bayer AG Main Business Overview
11.3.5 Bayer AG Latest Developments
11.4 ANI Pharmaceuticals, Inc.
11.4.1 ANI Pharmaceuticals, Inc. Company Information
11.4.2 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product Offered
11.4.3 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 ANI Pharmaceuticals, Inc. Main Business Overview
11.4.5 ANI Pharmaceuticals, Inc. Latest Developments
11.5 Sun Pharmaceutical Industries Ltd.
11.5.1 Sun Pharmaceutical Industries Ltd. Company Information
11.5.2 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product Offered
11.5.3 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
11.5.5 Sun Pharmaceutical Industries Ltd. Latest Developments
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Information
11.6.2 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product Offered
11.6.3 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.7 Apotex Inc.
11.7.1 Apotex Inc. Company Information
11.7.2 Apotex Inc. Antiandrogen Drugs Product Offered
11.7.3 Apotex Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Apotex Inc. Main Business Overview
11.7.5 Apotex Inc. Latest Developments
11.8 Intas Pharmaceuticals Ltd.
11.8.1 Intas Pharmaceuticals Ltd. Company Information
11.8.2 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product Offered
11.8.3 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Intas Pharmaceuticals Ltd. Main Business Overview
11.8.5 Intas Pharmaceuticals Ltd. Latest Developments
11.9 Cipla Ltd.
11.9.1 Cipla Ltd. Company Information
11.9.2 Cipla Ltd. Antiandrogen Drugs Product Offered
11.9.3 Cipla Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cipla Ltd. Main Business Overview
11.9.5 Cipla Ltd. Latest Developments
11.10 Zydus Lifesciences Ltd.
11.10.1 Zydus Lifesciences Ltd. Company Information
11.10.2 Zydus Lifesciences Ltd. Antiandrogen Drugs Product Offered
11.10.3 Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Zydus Lifesciences Ltd. Main Business Overview
11.10.5 Zydus Lifesciences Ltd. Latest Developments
11.11 Sandoz Group AG
11.11.1 Sandoz Group AG Company Information
11.11.2 Sandoz Group AG Antiandrogen Drugs Product Offered
11.11.3 Sandoz Group AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Sandoz Group AG Main Business Overview
11.11.5 Sandoz Group AG Latest Developments
11.12 Pinnacle Life Science Pvt. Ltd.
11.12.1 Pinnacle Life Science Pvt. Ltd. Company Information
11.12.2 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product Offered
11.12.3 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Pinnacle Life Science Pvt. Ltd. Main Business Overview
11.12.5 Pinnacle Life Science Pvt. Ltd. Latest Developments
11.13 Orion Corporation
11.13.1 Orion Corporation Company Information
11.13.2 Orion Corporation Antiandrogen Drugs Product Offered
11.13.3 Orion Corporation Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Orion Corporation Main Business Overview
11.13.5 Orion Corporation Latest Developments
11.14 Zhejiang Hisun Pharmaceutical Co., Ltd.
11.14.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
11.14.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.14.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business Overview
11.14.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
11.15 Shanghai Fudan Forward Pharmaceutical Co., Ltd.
11.15.1 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Company Information
11.15.2 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.15.3 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Main Business Overview
11.15.5 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Latest Developments
11.16 Shanghai Zhaohui Pharmaceutical Co., Ltd.
11.16.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
11.16.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.16.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Main Business Overview
11.16.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Latest Developments
11.17 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
11.17.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Company Information
11.17.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product Offered
11.17.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Main Business Overview
11.17.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Latest Developments
11.18 Aurisco Pharmaceutical Co., Ltd.
11.18.1 Aurisco Pharmaceutical Co., Ltd. Company Information
11.18.2 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.18.3 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Aurisco Pharmaceutical Co., Ltd. Main Business Overview
11.18.5 Aurisco Pharmaceutical Co., Ltd. Latest Developments
11.19 Qilu Pharmaceutical (Hainan) Co., Ltd.
11.19.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information
11.19.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product Offered
11.19.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business Overview
11.19.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
11.20 Chengdu Easton Biopharmaceuticals Co., Ltd.
11.20.1 Chengdu Easton Biopharmaceuticals Co., Ltd. Company Information
11.20.2 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product Offered
11.20.3 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Chengdu Easton Biopharmaceuticals Co., Ltd. Main Business Overview
11.20.5 Chengdu Easton Biopharmaceuticals Co., Ltd. Latest Developments
11.21 Sichuan Kelun Pharmaceutical Co., Ltd.
11.21.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
11.21.2 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.21.3 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Sichuan Kelun Pharmaceutical Co., Ltd. Main Business Overview
11.21.5 Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
11.22 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
11.22.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
11.22.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product Offered
11.22.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
11.22.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
11.23 Yangtze River Pharmaceutical Group Co., Ltd.
11.23.1 Yangtze River Pharmaceutical Group Co., Ltd. Company Information
11.23.2 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product Offered
11.23.3 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Yangtze River Pharmaceutical Group Co., Ltd. Main Business Overview
11.23.5 Yangtze River Pharmaceutical Group Co., Ltd. Latest Developments
11.24 Zhejiang Nuode Pharmaceutical Co., Ltd.
11.24.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Company Information
11.24.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.24.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Main Business Overview
11.24.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Latest Developments
11.25 Jiangxi Kerui Pharmaceutical Co., Ltd.
11.25.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
11.25.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.25.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Main Business Overview
11.25.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Latest Developments
11.26 Chengdu Better Pharmaceutical Co., Ltd.
11.26.1 Chengdu Better Pharmaceutical Co., Ltd. Company Information
11.26.2 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.26.3 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Chengdu Better Pharmaceutical Co., Ltd. Main Business Overview
11.26.5 Chengdu Better Pharmaceutical Co., Ltd. Latest Developments
11.27 Shenyang Hongqi Pharmaceutical Co., Ltd.
11.27.1 Shenyang Hongqi Pharmaceutical Co., Ltd. Company Information
11.27.2 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.27.3 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Shenyang Hongqi Pharmaceutical Co., Ltd. Main Business Overview
11.27.5 Shenyang Hongqi Pharmaceutical Co., Ltd. Latest Developments
11.28 Yichang Humanwell Pharmaceutical Co., Ltd.
11.28.1 Yichang Humanwell Pharmaceutical Co., Ltd. Company Information
11.28.2 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
11.28.3 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Yichang Humanwell Pharmaceutical Co., Ltd. Main Business Overview
11.28.5 Yichang Humanwell Pharmaceutical Co., Ltd. Latest Developments

12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Antiandrogen Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Antiandrogen Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Nonsteroidal Antiandrogens
Table 4. Major Players of Steroidal Antiandrogens
Table 5. Antiandrogen Drugs Market Size CAGR by Structure (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Antiandrogen Drugs Market Size by Structure (2021-2026) & ($ millions)
Table 7. Global Antiandrogen Drugs Market Size Market Share by Structure (2021-2026)
Table 8. Major Players of Tablets
Table 9. Major Players of Capsules
Table 10. Major Players of Soft Capsules
Table 11. Antiandrogen Drugs Market Size CAGR by Shape (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Antiandrogen Drugs Market Size by Shape (2021-2026) & ($ millions)
Table 13. Global Antiandrogen Drugs Market Size Market Share by Shape (2021-2026)
Table 14. Antiandrogen Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Antiandrogen Drugs Market Size by Application (2021-2026) & ($ millions)
Table 16. Global Antiandrogen Drugs Market Size Market Share by Application (2021-2026)
Table 17. Global Antiandrogen Drugs Revenue by Player (2021-2026) & ($ millions)
Table 18. Global Antiandrogen Drugs Revenue Market Share by Player (2021-2026)
Table 19. Antiandrogen Drugs Key Players Head office and Products Offered
Table 20. Antiandrogen Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Antiandrogen Drugs Market Size by Region (2021-2026) & ($ millions)
Table 24. Global Antiandrogen Drugs Market Size Market Share by Region (2021-2026)
Table 25. Global Antiandrogen Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 26. Global Antiandrogen Drugs Revenue Market Share by Country/Region (2021-2026)
Table 27. Americas Antiandrogen Drugs Market Size by Country (2021-2026) & ($ millions)
Table 28. Americas Antiandrogen Drugs Market Size Market Share by Country (2021-2026)
Table 29. Americas Antiandrogen Drugs Market Size by Structure (2021-2026) & ($ millions)
Table 30. Americas Antiandrogen Drugs Market Size Market Share by Structure (2021-2026)
Table 31. Americas Antiandrogen Drugs Market Size by Application (2021-2026) & ($ millions)
Table 32. Americas Antiandrogen Drugs Market Size Market Share by Application (2021-2026)
Table 33. APAC Antiandrogen Drugs Market Size by Region (2021-2026) & ($ millions)
Table 34. APAC Antiandrogen Drugs Market Size Market Share by Region (2021-2026)
Table 35. APAC Antiandrogen Drugs Market Size by Structure (2021-2026) & ($ millions)
Table 36. APAC Antiandrogen Drugs Market Size by Application (2021-2026) & ($ millions)
Table 37. Europe Antiandrogen Drugs Market Size by Country (2021-2026) & ($ millions)
Table 38. Europe Antiandrogen Drugs Market Size Market Share by Country (2021-2026)
Table 39. Europe Antiandrogen Drugs Market Size by Structure (2021-2026) & ($ millions)
Table 40. Europe Antiandrogen Drugs Market Size by Application (2021-2026) & ($ millions)
Table 41. Middle East & Africa Antiandrogen Drugs Market Size by Region (2021-2026) & ($ millions)
Table 42. Middle East & Africa Antiandrogen Drugs Market Size by Structure (2021-2026) & ($ millions)
Table 43. Middle East & Africa Antiandrogen Drugs Market Size by Application (2021-2026) & ($ millions)
Table 44. Key Market Drivers & Growth Opportunities of Antiandrogen Drugs
Table 45. Key Market Challenges & Risks of Antiandrogen Drugs
Table 46. Key Industry Trends of Antiandrogen Drugs
Table 47. Global Antiandrogen Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 48. Global Antiandrogen Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 49. Global Antiandrogen Drugs Market Size Forecast by Structure (2027-2032) & ($ millions)
Table 50. Global Antiandrogen Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 51. Astellas Pharma Inc. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 52. Astellas Pharma Inc. Antiandrogen Drugs Product Offered
Table 53. Astellas Pharma Inc. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Astellas Pharma Inc. Main Business
Table 55. Astellas Pharma Inc. Latest Developments
Table 56. Johnson & Johnson Innovative Medicine Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 57. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product Offered
Table 58. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Johnson & Johnson Innovative Medicine Main Business
Table 60. Johnson & Johnson Innovative Medicine Latest Developments
Table 61. Bayer AG Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 62. Bayer AG Antiandrogen Drugs Product Offered
Table 63. Bayer AG Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Bayer AG Main Business
Table 65. Bayer AG Latest Developments
Table 66. ANI Pharmaceuticals, Inc. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 67. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product Offered
Table 68. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. ANI Pharmaceuticals, Inc. Main Business
Table 70. ANI Pharmaceuticals, Inc. Latest Developments
Table 71. Sun Pharmaceutical Industries Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 72. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product Offered
Table 73. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Sun Pharmaceutical Industries Ltd. Main Business
Table 75. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 76. Teva Pharmaceutical Industries Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 77. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product Offered
Table 78. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Teva Pharmaceutical Industries Ltd. Main Business
Table 80. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 81. Apotex Inc. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 82. Apotex Inc. Antiandrogen Drugs Product Offered
Table 83. Apotex Inc. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Apotex Inc. Main Business
Table 85. Apotex Inc. Latest Developments
Table 86. Intas Pharmaceuticals Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 87. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product Offered
Table 88. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Intas Pharmaceuticals Ltd. Main Business
Table 90. Intas Pharmaceuticals Ltd. Latest Developments
Table 91. Cipla Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 92. Cipla Ltd. Antiandrogen Drugs Product Offered
Table 93. Cipla Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Cipla Ltd. Main Business
Table 95. Cipla Ltd. Latest Developments
Table 96. Zydus Lifesciences Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 97. Zydus Lifesciences Ltd. Antiandrogen Drugs Product Offered
Table 98. Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Zydus Lifesciences Ltd. Main Business
Table 100. Zydus Lifesciences Ltd. Latest Developments
Table 101. Sandoz Group AG Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 102. Sandoz Group AG Antiandrogen Drugs Product Offered
Table 103. Sandoz Group AG Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Sandoz Group AG Main Business
Table 105. Sandoz Group AG Latest Developments
Table 106. Pinnacle Life Science Pvt. Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 107. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product Offered
Table 108. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Pinnacle Life Science Pvt. Ltd. Main Business
Table 110. Pinnacle Life Science Pvt. Ltd. Latest Developments
Table 111. Orion Corporation Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 112. Orion Corporation Antiandrogen Drugs Product Offered
Table 113. Orion Corporation Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Orion Corporation Main Business
Table 115. Orion Corporation Latest Developments
Table 116. Zhejiang Hisun Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 117. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 118. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business
Table 120. Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
Table 121. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 122. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 123. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Main Business
Table 125. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Latest Developments
Table 126. Shanghai Zhaohui Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 127. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 128. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Shanghai Zhaohui Pharmaceutical Co., Ltd. Main Business
Table 130. Shanghai Zhaohui Pharmaceutical Co., Ltd. Latest Developments
Table 131. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 132. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product Offered
Table 133. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Main Business
Table 135. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Latest Developments
Table 136. Aurisco Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 137. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 138. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Aurisco Pharmaceutical Co., Ltd. Main Business
Table 140. Aurisco Pharmaceutical Co., Ltd. Latest Developments
Table 141. Qilu Pharmaceutical (Hainan) Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 142. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product Offered
Table 143. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business
Table 145. Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
Table 146. Chengdu Easton Biopharmaceuticals Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 147. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product Offered
Table 148. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Chengdu Easton Biopharmaceuticals Co., Ltd. Main Business
Table 150. Chengdu Easton Biopharmaceuticals Co., Ltd. Latest Developments
Table 151. Sichuan Kelun Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 152. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 153. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Sichuan Kelun Pharmaceutical Co., Ltd. Main Business
Table 155. Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
Table 156. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 157. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product Offered
Table 158. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business
Table 160. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
Table 161. Yangtze River Pharmaceutical Group Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 162. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product Offered
Table 163. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Yangtze River Pharmaceutical Group Co., Ltd. Main Business
Table 165. Yangtze River Pharmaceutical Group Co., Ltd. Latest Developments
Table 166. Zhejiang Nuode Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 167. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 168. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Zhejiang Nuode Pharmaceutical Co., Ltd. Main Business
Table 170. Zhejiang Nuode Pharmaceutical Co., Ltd. Latest Developments
Table 171. Jiangxi Kerui Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 172. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 173. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. Jiangxi Kerui Pharmaceutical Co., Ltd. Main Business
Table 175. Jiangxi Kerui Pharmaceutical Co., Ltd. Latest Developments
Table 176. Chengdu Better Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 177. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 178. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. Chengdu Better Pharmaceutical Co., Ltd. Main Business
Table 180. Chengdu Better Pharmaceutical Co., Ltd. Latest Developments
Table 181. Shenyang Hongqi Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 182. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 183. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. Shenyang Hongqi Pharmaceutical Co., Ltd. Main Business
Table 185. Shenyang Hongqi Pharmaceutical Co., Ltd. Latest Developments
Table 186. Yichang Humanwell Pharmaceutical Co., Ltd. Details, Company Type, Antiandrogen Drugs Area Served and Its Competitors
Table 187. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product Offered
Table 188. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. Yichang Humanwell Pharmaceutical Co., Ltd. Main Business
Table 190. Yichang Humanwell Pharmaceutical Co., Ltd. Latest Developments

List of Figures
Figure 1. Antiandrogen Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antiandrogen Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Antiandrogen Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Antiandrogen Drugs Sales Market Share by Country/Region (2025)
Figure 8. Antiandrogen Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Antiandrogen Drugs Market Size Market Share by Structure in 2025
Figure 10. Global Antiandrogen Drugs Market Size Market Share by Shape in 2025
Figure 11. Antiandrogen Drugs in Non-Metastatic Castration-Resistant Prostate Cancer
Figure 12. Global Antiandrogen Drugs Market: Non-Metastatic Castration-Resistant Prostate Cancer (2021-2026) & ($ millions)
Figure 13. Antiandrogen Drugs in Metastatic Castration-Resistant Prostate Cancer
Figure 14. Global Antiandrogen Drugs Market: Metastatic Castration-Resistant Prostate Cancer (2021-2026) & ($ millions)
Figure 15. Antiandrogen Drugs in Metastatic Castration-Sensitive Prostate Cancer
Figure 16. Global Antiandrogen Drugs Market: Metastatic Castration-Sensitive Prostate Cancer (2021-2026) & ($ millions)
Figure 17. Antiandrogen Drugs in High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
Figure 18. Global Antiandrogen Drugs Market: High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer (2021-2026) & ($ millions)
Figure 19. Global Antiandrogen Drugs Market Size Market Share by Application in 2025
Figure 20. Global Antiandrogen Drugs Revenue Market Share by Player in 2025
Figure 21. Global Antiandrogen Drugs Market Size Market Share by Region (2021-2026)
Figure 22. Americas Antiandrogen Drugs Market Size 2021-2026 ($ millions)
Figure 23. APAC Antiandrogen Drugs Market Size 2021-2026 ($ millions)
Figure 24. Europe Antiandrogen Drugs Market Size 2021-2026 ($ millions)
Figure 25. Middle East & Africa Antiandrogen Drugs Market Size 2021-2026 ($ millions)
Figure 26. Americas Antiandrogen Drugs Value Market Share by Country in 2025
Figure 27. United States Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. Canada Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 29. Mexico Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 30. Brazil Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 31. APAC Antiandrogen Drugs Market Size Market Share by Region in 2025
Figure 32. APAC Antiandrogen Drugs Market Size Market Share by Structure (2021-2026)
Figure 33. APAC Antiandrogen Drugs Market Size Market Share by Application (2021-2026)
Figure 34. China Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Japan Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. South Korea Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Southeast Asia Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 38. India Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 39. Australia Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. Europe Antiandrogen Drugs Market Size Market Share by Country in 2025
Figure 41. Europe Antiandrogen Drugs Market Size Market Share by Structure (2021-2026)
Figure 42. Europe Antiandrogen Drugs Market Size Market Share by Application (2021-2026)
Figure 43. Germany Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. France Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. UK Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 46. Italy Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 47. Russia Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 48. Middle East & Africa Antiandrogen Drugs Market Size Market Share by Region (2021-2026)
Figure 49. Middle East & Africa Antiandrogen Drugs Market Size Market Share by Structure (2021-2026)
Figure 50. Middle East & Africa Antiandrogen Drugs Market Size Market Share by Application (2021-2026)
Figure 51. Egypt Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. South Africa Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Israel Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 54. Turkey Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 55. GCC Countries Antiandrogen Drugs Market Size Growth 2021-2026 ($ millions)
Figure 56. Americas Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 57. APAC Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 58. Europe Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 59. Middle East & Africa Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 60. United States Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 61. Canada Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 62. Mexico Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 63. Brazil Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 64. China Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 65. Japan Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 66. Korea Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 67. Southeast Asia Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 68. India Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 69. Australia Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 70. Germany Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 71. France Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 72. UK Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 73. Italy Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 74. Russia Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 75. Egypt Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 76. South Africa Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 77. Israel Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 78. Turkey Antiandrogen Drugs Market Size 2027-2032 ($ millions)
Figure 79. Global Antiandrogen Drugs Market Size Market Share Forecast by Structure (2027-2032)
Figure 80. Global Antiandrogen Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 81. GCC Countries Antiandrogen Drugs Market Size 2027-2032 ($ millions)